Get startedLog in
    Picture of Connect Biopharma Holdings logo

    CNTB — Connect Biopharma Holdings Cashflow Statement

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapMomentum Trap
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Connect Biopharma Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

    R2021
    December 31st
    R2022
    December 31st
    R2023
    December 31st
    2024
    December 31st
    2025
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:20-F20-F10-K10-K10-K
    Standards:
    IFRS
    IFRS
    USG
    USG
    USG
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line-202-118-62.1-15.6-55.5
    Depreciation
    Amortisation
    Non-Cash Items1138.783.796.852.99
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital3.586.469.85-15.50.58
    Change in Accounts Receivable
    Change in Prepaid Expenses
    Change in Other Assets
    Change in Accounts Payable
    Change in Accrued Expenses
    Change in Payable / Accrued Expenses
    Change in Other Liabilities
    Cash from Operating Activities-84.3-102-47.7-23.6-51.2
    Capital Expenditures-3.88-4.41-0.081-0.75-0.434
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-1.32-81.875.1-2.710.3
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-5.21-86.275-3.459.82
    Financing Cash Flow Items-17.100.0440.033—
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities202-0.0850.0450.2271.09
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash113-18926.7-27.4-39.9